Science Current Events | Science News |

Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels

May 11, 2012

Results from a randomized trial in head and neck cancer

Barcelona, Spain: Patients with head and neck cancer and a low haemoglobin (Hb) level do not respond well to radiotherapy and therefore both control of their tumour and disease-free survival are compromised. Now researchers from The Netherlands have found that the problems caused by low Hb in these patients can be overcome by the use of a treatment known as ARCON therapy, in which accelerated radiotherapy is combined with carbogen (a mixture of carbon dioxide and oxygen) and the water-soluble vitamin nicotinamide [1].

Hans Kaanders, a professor of translational radiation oncology at Radboud University Nijmegen Medical Centre, Nijmegen, will tell the 31st conference of the European Society for Radiotherapy and Oncology [2] today (Friday) that the ARCON regime is the first to show a positive effect in patients with low Hb levels.

The researchers recruited 345 patients with squamous cell laryngeal cancer to a randomised trial: 174 received only accelerated radiotherapy (where two fractions per day are administered during the last week of radiotherapy in order to reduce the overall length of treatment), and 171 ARCON. Patients receiving ARCON inhaled carbogen during radiotherapy and took nicotinamide tablets prior to treatment. Pre-treatment Hb levels in the experimental group were measured and subsequently compared with the treatment outcomes in the accelerated radiotherapy alone arm.

They found that patients treated with accelerated radiotherapy alone who had normal Hb levels before treatment had significantly better control of the cancer at its primary site (76% as opposed to 56%), disease-free survival (72% and 48% respectively), and metastasis-free survival (90% and 70%) than those with low Hb levels.

"However, when we looked at the ARCON group, in cases where the patients had low Hb levels before treatment, we found that ARCON improved control of the cancer at its primary site, and improved disease-free and metastasis-free survival, so that the differences between them and patients with normal Hb levels were no longer significant," says Professor Kaanders' colleague Dr. Geert Janssens. The difference in local control between this low Hb group and the normal Hb accelerated radiotherapy (AR) alone group was only 1% (81% in the ARCON group versus 82% in the AR-only group); for disease-free survival, the difference was 77% (ARCON) as opposed to 70% (AR); and for metastasis-free survival 93% (ARCON) versus 89% (AR).

However, patients in both groups with low Hb levels pre-treatment still had a worse overall survival irrespective of which treatment they received. This is most likely due the fact that many patients with head and neck cancer also have other health problems that cannot be treated by radiotherapy, the researchers say.

"In the past, a number of investigators have tried to improve the outcome for patients with low Hb levels by giving erythropoietin, which stimulates red blood cell production, and red cell blood transfusion before and during treatment, but without success. ARCON is the first treatment to be found to correct for low Hb and therefore to improve prognosis in these patients," says Dr. Janssens. "We know that a decrease in Hb levels is associated with a reduced sensitivity to radiotherapy, and that this can switch the tumour microenvironment into a more aggressive subtype with a higher risk of loco-regional failure and of the development of distant metastases."

The lack of success with transfusion of red blood cells or erythropoietin suggests underlying adaptive mechanisms. Accelerated radiotherapy to counteract tumour cell repopulation during radiotherapy, combined with carbogen and nicotinamide, administered immediately before irradiation to increase the oxygen level, ensures that adaptive mechanisms cannot erode the effect, and this is probably the key to success of the ARCON regime in patients with low HB levels at presentation, the researchers say.

"We believe that, at a time when healthcare systems are under increasing pressure to introduce expensive targeted treatments, the use of such a low cost, effective therapy should only be encouraged," Professor Kaanders will conclude.

Prof Vincenzo Valentini, radiation oncologist at the Policlinico Universitario A. Gemelli in Rome, Italy, and President of ESTRO, said: "We know that the degree of oxygenation of tumours in laryngeal cancer patients is directly related to the damage that can be caused to them by radiotherapy. This important study shows that, in patients with low haemoglobin levels, it is possible to reoxygenate the tumour by using the simple and cost-effective ARCON regime, and therefore increase the effectiveness of radiation treatment."


Abstract no: OC 217, 10.30 hrs, Friday 11 May, Auditorium

[1] When carbogen is inhaled, the increased level of carbon dioxide causes the brain to react to potential suffocation because it interprets the increase in blood carbon dioxide as a decrease in oxygen level, and the body compensates by reducing hypoxia. Nicotinamide also reduces hypoxia by increasing blood flow.

[2] This year the ESTRO conference is held in parallel with the World Congress of Brachytherapy, both taking place in Barcelona from May 9-13.

European Society for Radiotherapy and Oncology (ESTRO)

Related Radiotherapy Current Events and Radiotherapy News Articles

Yoga may lessen side effects in men undergoing prostate cancer treatment
Men with prostate cancer who are undergoing radiation therapy can benefit from yoga, researchers at the Perelman School of Medicine at the University of Pennsylvania reported at the Society of Integrative Oncology's 12th International Conference.

Malignant network makes brain cancer resistant
Incurable astrocytomas, including the particularly malignant glioblastomas, diffusively grow like mycelium into healthy brain tissue.

NTU scientists use dead bacteria to kill colorectal cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.

Liquid biopsy of cerebrospinal fluid for more effective policing of brain tumors
Reported in the journal Nature Communications, the Vall d'Hebron Institute of OncologyÂ's (VHIO) Gene Expression and Cancer Group, led by Joan Seoane, has pioneered research evidencing the use of cerebrospinal fluid (CSF) as liquid biopsy for the potential prognosis, treatment, identification and tracking of brain tumor genomic alterations not only in real time but over time.

Scientists discover how to better map brain tumors
Scientists have discovered a protein that helps map the edge of brain tumours more clearly so they show up on magnetic resonance imaging (MRI) scans, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.

Expanding global access to radiotherapy
Queen's University researcher Timothy Hanna has co-authored a Lancet Oncology study that suggests as many as 90 per cent of people in low-income countries lack access to radiotherapy treatment. The lack of access to radiotherapy costs millions of lives and billions of dollars in lost economic growth in low- and middle-income countries.

Cancer diagnosis while pregnant should not lead to treatment delay or end of pregnancy
Women who are pregnant when diagnosed with cancer can start treatment for their disease immediately and do not need to terminate their pregnancy due to worries over the effects of therapy on the development of their child.

Primary surgery is linked with survival benefit in patients with advanced throat cancer
Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery.

Post-diagnosis aspirin improves survival in all gastrointestinal cancers
Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show.

Tracking down the beam
Proton beams are new high-precision weapons in the fight against cancer. However, uncertainty with regard to the range of the beams has prevented the full exploitation of the potential of this method until now.
More Radiotherapy Current Events and Radiotherapy News Articles

Clinical Radiation Oncology, 4e

Clinical Radiation Oncology, 4e
by Leonard L. Gunderson MD MS FASTRO (Author), Joel E. Tepper MD (Author)

Perfect for radiation oncology physicians and residents needing a multidisciplinary, treatment-focused resource, this updated edition continues to provide the latest knowledge in this consistently growing field. Not only will you broaden your understanding of the basic biology of disease processes, you'll also access updated treatment algorithms, information on techniques, and state-of-the-art modalities. The consistent and concise format provides just the right amount of information, making Clinical Radiation Oncology a welcome resource for use by the entire radiation oncology team.Content is templated and divided into three sections -- Scientific Foundations of Radiation Oncology, Techniques and Modalities, and Disease Sites - for quick access to information. Disease Sites chapters...

Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy (Medical Radiology)

Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy (Medical Radiology)
by Nancy Y. Lee (Editor), Nadeem Riaz (Editor), Jiade J. Lu (Editor)

This textbook is designed to help the busy radiation oncologist to accurately and confidently delineate tumor volumes for conformal radiation therapy (including IMRT). The book provides an atlas of clinical target volumes (CTVs) for commonly encountered cancers, with each chapter illustrating CTV delineation on a slice-by-slice basis, on planning CT images. Common anatomic variants for each tumor are represented in individual illustrations, with annotations highlighting differences in coverage. The anatomy of each site and patterns of lymphatic drainage are discussed, and their influence on the design of CTVs is explained in detail. Utilization of other imaging modalities, including MRI, to delineate volumes is highlighted. Key details of simulation and planning are briefly reviewed....

Khan's The Physics of Radiation Therapy

Khan's The Physics of Radiation Therapy
by Faiz M. Khan PhD (Author), John P. Gibbons PhD (Author)

Expand your understanding of the physics and practical clinical applications of advanced radiation therapy technologies with Khan's The Physics of Radiation Therapy, 5th edition, the book that set the standard in the field. This classic full-color text helps the entire radiation therapy team—radiation oncologists, medical physicists, dosimetrists, and radiation therapists—develop a thorough understanding of 3D conformal radiotherapy (3D-CRT), stereotactic radiosurgery (SRS), high dose-rate remote afterloaders (HDR), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), Volumetric Modulated Arc Therapy (VMAT), and proton beam therapy, as well as the physical concepts underlying treatment planning, treatment delivery, and dosimetry.

In preparing...

Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy

Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
by Rajni A Sethi (Editor), Igor J Barani (Editor), David A Larson (Editor), Mack Roach III (Editor)

This handbook concisely summarizes state-of-the-art information about stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), including the history and development of these modalities, the biologic rationale for these technologies, typical practices, and reported results. Developed as a companion to Handbook of Evidence-Based Radiotherapy, Second Edition, edited by Eric Hansen and Mack Roach, III, it is organized by disease site and presents treatment techniques and recommended imaging; safety and quality assurance; toxicities and management; recommended follow-up; and supporting evidence. Inclusion of evidence-based guidelines is intended to help inform decisions regarding the appropriateness of SRS and SBRT and guide treatment and evaluation. Handbook of...

Basic Radiotherapy Physics and Biology

Basic Radiotherapy Physics and Biology
by David S. Chang (Author), Foster D. Lasley (Author), Indra J. Das (Author), Marc S. Mendonca (Author), Joseph R. Dynlacht (Author)

This book is a concise and well-illustrated review of the physics and biology of radiation therapy intended for radiation oncology residents, radiation therapists, dosimetrists, and physicists. It presents topics that are included on the Radiation Therapy Physics and Biology examinations and is designed with the intent of presenting information in an easily digestible format with maximum retention in mind. The inclusion of mnemonics, rules of thumb, and reader-friendly illustrations throughout the book help to make difficult concepts easier to grasp. Basic Radiotherapy Physics and Biology is a valuable reference for students and prospective students in every discipline of radiation oncology.

Perez & Brady's Principles and Practice of Radiation Oncology (Perez and Bradys Principles and Practice of Radiation Oncology)

Perez & Brady's Principles and Practice of Radiation Oncology (Perez and Bradys Principles and Practice of Radiation Oncology)
by Edward C. Halperin MD (Author), Luther W. Brady MD (Author), Carlos A. Perez MD (Author), David E. Wazer MD (Author)

Inside the Sixth Edition of this now-classic reference, you will discover encyclopedic coverage of topics ranging from basic science to sophisticated computer-based radiation therapy treatment planning and supportive care. The book’s comprehensive scope and abundantly illustrated format provide you with better understanding of the natural history of cancer, the physical methods of radiation application, the effects of radiation on normal tissues, and the most judicious ways in which you can employ radiation therapy in patient care. Traditionally available as a printed textbook, now it comes with a completely revamped digital experience, powered by Inkling! NEW to the Sixth Edition…• Site-specific chapters include relevant background information on each tumor—including...

Stereotactic Body Radiotherapy: A Practical Guide

Stereotactic Body Radiotherapy: A Practical Guide
by Andrew Gaya (Editor), Anand Mahadevan (Editor)

This is a single, comprehensive handbook for clinical oncology trainees and consultants, covering the basic aspects of stereotactic radiotherapy systems and treatment.

Radiation Oncology - A Question Based Review 2nd Edition

Radiation Oncology - A Question Based Review 2nd Edition
by Borislav Hristov (Editor), Steven H. Lin MD PhD (Editor), John P. Christodouleas MD MPH (Editor)

Test and solidify your knowledge of radiation oncology with Radiation Oncology: A Question-Based Review. This book’s Q&A format doesn’t merely encourage rote memorization, but expounds on most answers’ reasoning, background information, and clinical context to foster your complete understanding. Written by top experts, with each chapter authored by at least one resident and one faculty member, Radiation Oncology: A Question-Based Review is the perfect learning tool for students and physicians who are seeking to strengthen their long-term command of radiation oncology.

FEATURESCovers all sites and cancer types currently treated with radiotherapy with an emphasis on treatment recommendations and the evidence behind them.Detailed questions on the natural history,...

Radiotherapy for Head and Neck Cancers: Indications and Techniques

Radiotherapy for Head and Neck Cancers: Indications and Techniques
by K. Kian Ang MD PhD (Author), Adam S. Garden MD (Author)

Long established as a staple reference for all radiation oncologists, Radiotherapy for Head and Neck Cancers: Indications and Techniques is now in its Fourth Edition. This completely updated edition presents the state-of-the-art protocols currently used at the MD Anderson Cancer Center and thoroughly explains the principles, nomenclature, and clinical use of intensity-modulated radiotherapy (IMRT). The first section discusses the practical aspects of external beam therapy, brachytherapy, and endocavitary beam therapy and offers guidelines on patient care before and during radiotherapy. The second section provides detailed coverage of site-specific indications and techniques.

IMRT with DART and Brachytherapy: A Primer on 4-Dimensional Intensity Modulated Radiotherapy (4D-IG IMRT), Dynamic Adaptive Radiotherapy, and Brachytherapy for Informed Patients

IMRT with DART and Brachytherapy: A Primer on 4-Dimensional Intensity Modulated Radiotherapy (4D-IG IMRT), Dynamic Adaptive Radiotherapy, and Brachytherapy for Informed Patients
by Michael J. Dattoli M.D. (Author), Jennifer Cash ARNP (Author)

This newly updated and revised educational booklet is part of the Dattoli Cancer Foundation's Prostate Cancer Essentials for Survival series. It is a primer for informed patients and provides a comprehensive overview of Dynamic Adaptive Radiation Therapy (DART) when utilized for treating prostate cancer patients in conjunction with all modalities associated with 4 Dimensional Image Guided Intensity Modulated Radiation Therapy (4D IG-IMRT). The authors are leading cancer care professionals specializing in state-of-the-art radiotherapy and they offer the most practical and up-to-date medical information. Dr. Dattoli shares his wealth of knowledge and experience as Physician-in-Chief of the Dattoli Cancer Center & Brachytherapy Research Institute, which has the largest combination...

© 2015